SCHEDULE 13D

Company

HERON THERAPEUTICS, INC. /DE/

Filed

February 6, 2023

Accession Number

0000921895-23-000284

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →